Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
Braun
F
F
Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany.
Lorf
T
T
Grupp
C
C
Schütz
E
E
Sattler
B
B
Canelo
R
R
Müller
G A
GA
Ringe
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D002102:Cadaver; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012307:Risk Factors; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus